Difficulty: Medium
Average Score: 78%
Practice
The concentration of dopamine in the basal ganglia of the brain is reduced in parkinsonism.
Correct answer
A
Rationale
In Parkinson's disease, a neurodegenerative disorder affecting the central nervous system, there is a reduction in the concentration of dopamine in the basal ganglia of the brain. Dopamine is a neurotransmitter responsible for coordinating smooth muscle movement and is crucial for the proper functioning of the basal ganglia. The decrease in dopamine levels leads to the characteristic motor symptoms of Parkinson's disease such as tremors, rigidity, and bradykinesia.
Option A, "TRUE", is the correct answer because it accurately reflects the relationship between dopamine concentration in the basal ganglia and Parkinsonism. This reduction in dopamine levels is a key feature in the pathophysiology of Parkinson's disease.
Options B, "FALSE", and C, "None", are incorrect because they do not align with the established scientific understanding of Parkinson's disease. The statement in option A is supported by extensive research and clinical evidence.
Option D, "All of the above", is also incorrect as it does not apply to this particular question. The question specifically asks about the concentration of dopamine in the basal ganglia in relation to Parkinsonism, and selecting "All of the above" would imply that all options are correct, which is not the case.
In an educational context, understanding the role of dopamine in Parkinson's disease is crucial for healthcare professionals, especially those working in fields like pharmacology and neurology. This knowledge helps in the diagnosis, treatment, and management of patients with Parkinsonism, highlighting the importance of pharmacological interventions aimed at restoring dopamine levels in the brain to alleviate symptoms and improve quality of life for individuals affected by this condition.
Option A, "TRUE", is the correct answer because it accurately reflects the relationship between dopamine concentration in the basal ganglia and Parkinsonism. This reduction in dopamine levels is a key feature in the pathophysiology of Parkinson's disease.
Options B, "FALSE", and C, "None", are incorrect because they do not align with the established scientific understanding of Parkinson's disease. The statement in option A is supported by extensive research and clinical evidence.
Option D, "All of the above", is also incorrect as it does not apply to this particular question. The question specifically asks about the concentration of dopamine in the basal ganglia in relation to Parkinsonism, and selecting "All of the above" would imply that all options are correct, which is not the case.
In an educational context, understanding the role of dopamine in Parkinson's disease is crucial for healthcare professionals, especially those working in fields like pharmacology and neurology. This knowledge helps in the diagnosis, treatment, and management of patients with Parkinsonism, highlighting the importance of pharmacological interventions aimed at restoring dopamine levels in the brain to alleviate symptoms and improve quality of life for individuals affected by this condition.